Sep 28, 2015 8:00am EDT Adaptimmune to Participate in the Leerink Partners Inaugural Immuno-Oncology Roundtable
Sep 09, 2015 8:30am EDT Adaptimmune Announces Expansion of Senior Team to Augment Clinical Expertise and Support Growth
Sep 03, 2015 8:45am EDT Adaptimmune to Participate in the 22nd Annual BioCentury 'NewsMakers in the Biotech Industry' Conference
Sep 01, 2015 7:30am EDT Adaptimmune Expands Trial of T-cell Therapy for Synovial Sarcoma and Achieves Clinical Milestones
Jul 20, 2015 11:01am EDT Adaptimmune's NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence, Clinical Activity and Tolerability in Clinical Study in Multiple Myeloma Patients
Jul 02, 2015 6:00am EDT Adaptimmune Announces FDA Acceptance of Investigational New Drug (IND) Application for MAGE-A10 T in Patients With Non-Small Cell Lung Cancer
May 30, 2015 12:30pm EDT Adaptimmune Announces Data From Clinical Studies of NY-ESO-1 Specific T-Cells in Multiple Cancers at the 2015 Annual American Society of Clinical Oncology (ASCO) Meeting
